National Medical Products Administration (nmpa) - Nanotechnology

Relevant Publications

Association of outpatient fluoroquinolone prescribing with the national medical products administration announcements of label changes in China.

Issue Release: 2024

Pharmacokinetics and Bioequivalence of Two Formulations of Azithromycin Tablets: A Randomized, Single-Dose, Three-Period, Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.

Issue Release: 2024

Assessment of the implementation of accelerated drug marketing registration procedures for antineoplastic and immunomodulating agents in China: based on 2016-2022 review data.

Issue Release: 2024

Establishment of RWS guidance reflecting contributions of China to regulatory science.

Issue Release: 2024

[Chinese expert consensus on iruplinalkib for the treatment of locally advanced or metastatic ALK-positive non-small cell lung cancer (2024 edition)].

Issue Release: 2024

The Impact of Regulatory Reforms in China on Drug Lag: The Role of Clinical Development Strategies.

Issue Release: 2024

[Chinese expert consensus on the management of clinical pathway and adverse events of trastuzumab deruxtecan (2024 edition)].

Issue Release: 2024

The Use of Real-World Evidence for Regulatory Decisions in China.

Issue Release: 2024

Safety assessment of Wuzhuyu decoction extract: acute and subacute oral toxicity studies in rats.

Issue Release: 2024

Cost-effectiveness analysis of camrelizumab plus paclitaxel and carboplatin sintilimab plus gemcitabine and cisplatin or carboplatin for the first-line treatment of local advanced or metastatic squamous NSCLC in Chinese mainland.

Issue Release: 2024

Integrating Data Mining with Metabolomics to Analyze the Mechanism of the \"Pearl-Borneol\" Pair in Promoting Healing of Diabetic Wounds.

Issue Release: 2024

P4HB maintains Wnt-dependent stemness in glioblastoma stem cells as a precision therapeutic target and serum marker.

Issue Release: 2024

Comparative effectiveness and safety of imported and domestic immune checkpoint inhibitors in China: a systematic review and pairwise and network meta-analyses.

Issue Release: 2024

Efficacy and Safety of Bevacizumab Biosimilar (Encoda) Compared With Reference Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer: A Multicenter, Real-World Study.

Issue Release: 2024

Synthesis and clinical application of new drugs approved by NMPA in 2023.

Issue Release: 2024

Compassionate use of contezolid in a toddler with severe community-acquired pneumonia induced by staphylococcus aureus: a case report and follow-up.

Issue Release: 2024

Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial.

Issue Release: 2024

Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement.

Issue Release: 2024

Commercial Chinese polyherbal preparation: current status and future perspectives.

Issue Release: 2024

[Chinese expert consensus on treatment of osteoporotic fractures with teriparatide (2024 edition)].

Issue Release: 2024

How Does Indexing Benefit Researchers?

What are the Challenges in Nanotechnology Application Development?

What is Friction and Why is it Important?

Are There Any Current Applications of Nanosensors in Pollution Detection?

How Do Steric Interactions Affect Nanoparticle Stability?

Why is Dimensionality Reduction Important in Nanotechnology?

What are the Advantages of 3D NAND Flash?

How are Macroporous Materials Created?

What is the Zeeman Effect?

Why is Signal Attenuation Important in Nanotechnology?

National Medical Products Administration (nmpa) - Nanotechnology

Relevant Publications

Partnered Content Networks

Relevant Topics